David Reimer
Impact in
- Microbiology top 10%
- Microbial infections and disease research
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Inhalation and Respiratory Drug Delivery 3
- Kidney Stones and Urolithiasis Treatments 2
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Neonatal Respiratory Health Research 1
- Co-authors
- Olga B. Garbuzenko (3 shared papers)Tamara Minko (3 shared papers)Vitaly P. Pozharov (2 shared papers)Kenneth R. Reuhl (3 shared papers)Debra L. Laskin (2 shared papers)Maha Saad (1 shared paper)Min Zhang (1 shared paper)Alexandre A. Vetcher (1 shared paper)
- Journals
- Journal of the American Association for Laboratory Animal Science (2 papers)Journal of Veterinary Internal Medicine (2 papers)Pharmaceutical Research (1 paper)Toxicology and Applied Pharmacology (1 paper)Urology (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
David Reimer
11 papers receiving 585 citations
Peers
Comparison fields: 5 of 90
- Microbiology 49
- Pharmaceutical Science 47
- Pulmonary and Respiratory Medicine 176
- Biomaterials 78
- Pharmacology 57
Countries citing papers authored by David Reimer
This map shows the geographic impact of David Reimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Reimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Reimer more than expected).
Fields of papers citing papers by David Reimer
This network shows the impact of papers produced by David Reimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Reimer. The network helps show where David Reimer may publish in the future.
Co-authors
The 25 scholars most cited alongside David Reimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 133 | |
| 2 | 2010 | 92 | |
| 3 | 2012 | 70 | |
| 4 | 1999 | 66 | |
| 5 | 2017 | 57 | |
| 6 | 1995 | 56 | |
| 7 | 2010 | 51 | |
| 8 | 2010 | 24 | |
| 9 | 2014 | 20 | |
| 10 | 1999 | 16 | |
| 11 | 2009 | 14 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 | |
| 14 | 2023 | 0 |
About David Reimer
David Reimer is a scholar working on Pulmonary and Respiratory Medicine, Small Animals, Public Health, Environmental and Occupational Health, Molecular Biology and Pharmacology, having authored 14 papers that have together received 599 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (3 papers), Inflammatory mediators and NSAID effects (2 papers), Kidney Stones and Urolithiasis Treatments (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Neonatal Respiratory Health Research (1 paper), Extracellular vesicles in disease (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Injury Epidemiology and Prevention (1 paper). The work is most often cited by research in Microbiology (49 citations), Pharmaceutical Science (47 citations), Pulmonary and Respiratory Medicine (176 citations), Biomaterials (78 citations) and Pharmacology (57 citations). David Reimer has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Olga B. Garbuzenko, Tamara Minko, Vitaly P. Pozharov, Kenneth R. Reuhl, Debra L. Laskin, Maha Saad, Min Zhang, Alexandre A. Vetcher, Viatcheslav A. Soldatenkov and Robert B. Duncan. Their work appears in journals such as Journal of the American Association for Laboratory Animal Science, Journal of Veterinary Internal Medicine, Pharmaceutical Research, Toxicology and Applied Pharmacology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.